长链非编码RNA在精神分裂症的变化与阳性、阴性症状的研究

doi:10.3877/cma.j.issn.2095-123X.2017.02.004

中华脑科疾病与康复杂志(电子版) ›› 2017, Vol. 07 ›› Issue (02) : 64 -70. doi: 10.3877/cma.j.issn.2095-123X.2017.02.004

所属专题：精准医疗；总编推荐；文献；

临床研究

长链非编码RNA在精神分裂症的变化与阳性、阴性症状的研究

何明骏¹, 姚高峰¹^,^†(

), 张理义¹, 孔令明¹, 牛威¹, 陈升东¹, 仲爱芳¹

^1. 213000　江苏常州，解放军102医院全军心理疾病防治中心

收稿日期:2016-09-05 出版日期:2017-04-01
通信作者: 姚高峰
基金资助:
中国人民解放军总后勤部科研基金"十二五"重大项目(编号：BWS14J027)

A study on the relation of positive and negative symptoms to long non-coding RNAs with altered expressions in schizophrenia

Mingjun He¹, Gaofeng Yao¹^,^†(), Liyi Zhang¹, Lingming Kong¹, Wei Niu¹, Shendong Chen¹, Aifang Zhong¹

^1. Prevention and Treatment Center for Psychological Diseases, No.102 Hospital of the Chinese People′s Liberation Army, Changzhou 213003, China

Received:2016-09-05 Published:2017-04-01
Corresponding author: Gaofeng Yao
About author:
Corresponding author: Yao Gaofeng, Email: yao_gaofeng@126.com

全文 ( ) 下载PDF ( ) 导出引用

引用本文：

何明骏, 姚高峰, 张理义, 孔令明, 牛威, 陈升东, 仲爱芳. 长链非编码RNA在精神分裂症的变化与阳性、阴性症状的研究[J]. 中华脑科疾病与康复杂志(电子版), 2017, 07(02): 64-70.

Mingjun He, Gaofeng Yao, Liyi Zhang, Lingming Kong, Wei Niu, Shendong Chen, Aifang Zhong. A study on the relation of positive and negative symptoms to long non-coding RNAs with altered expressions in schizophrenia[J]. Chinese Journal of Brain Diseases and Rehabilitation(Electronic Edition), 2017, 07(02): 64-70.

目的

探讨精神分裂症外周血长链非编码RNA(lncRNA)差异表达及其与阳性、阴性症状的关系。

方法

采用基因芯片筛查病例组与正常对照组之间有差异表达的lncRNA。2012年8月至2014年6月于解放军第102医院门诊以及精神科病房连续入组的96例患者和44例健康对照者，用qPCR进行验证。并用曼-惠特尼U检验、t检验、相关分析等分析精神分裂症患者lncRNA表达量与阳性、阴性症状的相关性。

结果

1．病例组结果显示，与对照组比较，其外周血单核细胞中3种lncRNA(NONHSAT021545、NONHSAT089447、NONHSAT098126)表达显著上调，差异有统计学意义(t＝－2.460～－2.038，P<0.05)。2.精神分裂症中有差异表达的lncRNA与精神分裂症阳性、阴性症状量表分(PANSS)的相关分析提示，有差异表达的10种lncRNA均与精神分裂症阳性症状量表分显著正相关(r＝0.231～0.276, P均<0.05)。3.精神分裂症中有差异表达的lncRNA与阳性、阴性症状量表各因子分的相关分析显示，有差异表达的10种lncRNA均与激活性显著正相关(r＝0.243～0.352, P均<0.05); TCONS_l2_00025502、ENST00000563823、ENST00000521622、TCONS_l2_00021339及NONHSAT104778与偏执显著正相关(r＝0.201～0.223, P<0.05);有差异表达的10种lncRNA均与攻击性显著正相关(r＝0.207～0.259, P<0.05)。4.对高表达与低表达组的阳性、阴性症状进行比较发现，NONHSAT021545、NONHSAT041499高表达组的激活性和攻击性得分显著低于低表达组(P均<0.05)。

结论

lncRNA的异常表达可能与精神分裂症有某种关联，某些异常表达的lncRNA与特定的阳性、阴性症状特征关系密切。

关键词: 精神分裂症, 长链非编码RNA, 生物标记物, 阳性与阴性症状量表

Objective

To explore the relation of positive and negative symptoms to long non coding RNAs (lncRNAs) with altered expressions in peripheral blood of schizophrenia.

Methods

Gene microarray was used to screen the lncRNAs which expressed differently in case group compared to that in control group, and the screened lncRNAs were validated by real-time fluorescence quantitative PCR(qRT-PCR) in 96 schizophrenic patients in the outpatient service and psychiatric wards of No.102 Hospital of the Chinese People′s Liberation Army and 44 healthy people from Auguest 2012 to June 2014. And Mann-Whitney U test, t test and correlation analysis were used to analyze the correlations of positive and negative symptoms with the expression levels of lncRNAs in schizophrenic patients.

Results

1. Compared to control group, 3 lncRNAs(NONHSAT021545、NONHSAT089447、NONHSAT098126) in case group were greatly high-regulated and the differences were statistically significant (t=-2.460~-2.038, P<0.05). 2. The correlation analysis on differentially-expressed lncRNAs with the scores of positive and negative symptom scale (PANSS) revealed that PR1~PR10 with altered expressions were positively associated with the scores of positive and negative symptom scale (r=0.231~0.276, all P<0.05). 3. PR1~PR10 with altered expressions were positively correlated to activation(r=0.243~0.352, all P<0.05); TCONS_l2_00025502、ENST00000563823、ENST00000521622、TCONS_l2_00021339 and NONHSAT104778 were positively correlated to stubborn(r=0.201~0.223, P<0.05); PR1~PR10 were positively correlated to aggressivity(r=0.207~0.259, P<0.05). 4. The scores of activation and aggressivity of NONHSAT021545 and NONHSAT041499 in high-expressed group were significantly lower than that in low-expressed group(P<0.05 or 0.01).

Conclusion

The abnormal expression of lncRNAs may have some relevance with schizophrenia, and to be specific, some lncRNAs may be associated with the positive and negative symptoms.

Key words: Schizophrenia, Long non-coding RNA, Biomarker, Positive and negative symptom scale

表1 芯片中筛查中差异表达的10种lncRNA

TargetID	FC (abs)	Regulation	P
NONHSAT021545	3.697919	up	0.023714
NONHSAT089447	3.514152	up	0.038920
NONHSAT098126	4.610542	up	0.047744

表1 芯片中筛查中差异表达的10种lncRNA

TargetID	FC (abs)	Regulation	P
NONHSAT021545	3.697919	up	0.023714
NONHSAT089447	3.514152	up	0.038920
NONHSAT098126	4.610542	up	0.047744

表2 病例组与对照组lncRNA比较(ΔCt±SD)

lncRNA	例数	PR1	PR2	PR3	PR4	PR5	PR6	PR7	PR8	PR9	PR10
病例组	96	4.14±4.28	5.03±4.72	5.21±4.95	4.23±4.79	3.60±4.57	4.51±4.56	5.05±3.98	5.80±4.82	3.75±4.87	5.67±4.80
对照组	44	5.73±4.43	6.50±5.11	6.83±5.38	6.28±5.37	5.31±4.65	6.48±4.50	6.70±4.45	7.50±5.33	5.55±5.33	4.76±5.10
Z值	?	－2.042	－1.571	－1.688	－2.038	－1.921	－2.177	－2.460	－1.742	－1.836	－1.737
P值	?	0.041	0.116	0.091	0.042	0.055	0.029	0.014	0.082	0.066	0.082

表2 病例组与对照组lncRNA比较(ΔCt±SD)

lncRNA	例数	PR1	PR2	PR3	PR4	PR5	PR6	PR7	PR8	PR9	PR10
病例组	96	4.14±4.28	5.03±4.72	5.21±4.95	4.23±4.79	3.60±4.57	4.51±4.56	5.05±3.98	5.80±4.82	3.75±4.87	5.67±4.80
对照组	44	5.73±4.43	6.50±5.11	6.83±5.38	6.28±5.37	5.31±4.65	6.48±4.50	6.70±4.45	7.50±5.33	5.55±5.33	4.76±5.10
Z值	?	－2.042	－1.571	－1.688	－2.038	－1.921	－2.177	－2.460	－1.742	－1.836	－1.737
P值	?	0.041	0.116	0.091	0.042	0.055	0.029	0.014	0.082	0.066	0.082

表3 病例组lncRNA与PANSS量表分的相关分析(n＝96)

lncRNA	阳性量表	阴性量表	一般病理量表	复合量表
ENST00000394742	0.244^a	－0.004	－0.006	0.000
TCONS_l2_00025502	0.276^b	－0.019	－0.023	0.014
NONHSAT098126	0.252^a	0.012	－0.026	－0.006
NONHSAT089447	0.258^a	－0.009	－0.018	0.030
ENST00000563823	0.257^a	0.011	－0.007	0.030
NONHSAT021545	0.249^a	－0.025	－0.027	0.008
NONHSAT041499	0.231^a	0.002	0.011	－0.041
ENST00000521622	0.247^a	0.007	0.020	0.028
TCONS_l2_00021339	0.260^a	0.009	0.002	0.055
NONHSAT104778	0.247^a	－0.007	－0.006	0.021

表3 病例组lncRNA与PANSS量表分的相关分析(n＝96)

lncRNA	阳性量表	阴性量表	一般病理量表	复合量表
ENST00000394742	0.244^a	－0.004	－0.006	0.000
TCONS_l2_00025502	0.276^b	－0.019	－0.023	0.014
NONHSAT098126	0.252^a	0.012	－0.026	－0.006
NONHSAT089447	0.258^a	－0.009	－0.018	0.030
ENST00000563823	0.257^a	0.011	－0.007	0.030
NONHSAT021545	0.249^a	－0.025	－0.027	0.008
NONHSAT041499	0.231^a	0.002	0.011	－0.041
ENST00000521622	0.247^a	0.007	0.020	0.028
TCONS_l2_00021339	0.260^a	0.009	0.002	0.055
NONHSAT104778	0.247^a	－0.007	－0.006	0.021

表4 病例组lncRNA与PANSS量表各症状群的相关分析(n＝96)

lncRNA	反应缺乏	思维障碍	激活性	偏执	抑郁	攻击性
PR1	0.025	0.059	0.289^b	0.190	-0.036	0.223^a
PR2	0.015	0.073	0.306^b	0.223^a	-0.080	0.229^a
PR3	0.056	0.024	0.352^b	0.198	-0.023	0.207^a
PR4	0.022	0.056	0.316^b	0.200	-0.077	0.236^a
PR5	0.037	0.049	0.316^b	0.206^a	-0.063	0.236^a
PR6	0.000	0.064	0.300^b	0.179	-0.044	0.211^a
PR7	0.031	0.088	0.243^a	0.162	-0.032	0.208^a
PR8	0.036	0.041	0.319^b	0.211^a	-0.044	0.250^a
PR9	0.042	0.048	0.327^b	0.218^a	-0.066	0.259^a
PR10	0.027	0.051	0.314^b	0.201^a	-0.066	0.238^a

表4 病例组lncRNA与PANSS量表各症状群的相关分析(n＝96)

lncRNA	反应缺乏	思维障碍	激活性	偏执	抑郁	攻击性
PR1	0.025	0.059	0.289^b	0.190	-0.036	0.223^a
PR2	0.015	0.073	0.306^b	0.223^a	-0.080	0.229^a
PR3	0.056	0.024	0.352^b	0.198	-0.023	0.207^a
PR4	0.022	0.056	0.316^b	0.200	-0.077	0.236^a
PR5	0.037	0.049	0.316^b	0.206^a	-0.063	0.236^a
PR6	0.000	0.064	0.300^b	0.179	-0.044	0.211^a
PR7	0.031	0.088	0.243^a	0.162	-0.032	0.208^a
PR8	0.036	0.041	0.319^b	0.211^a	-0.044	0.250^a
PR9	0.042	0.048	0.327^b	0.218^a	-0.066	0.259^a
PR10	0.027	0.051	0.314^b	0.201^a	-0.066	0.238^a

表5 病例组lncRNA高表达组和低表达组阳性、阴性症状的比较(±s)

因子	NONHSAT089447		t	P值	NONHSAT021545		t	P值	NONHSAT041499		t	P值
因子	高表达组	低表达组	t	P值	高表达组	低表达组	t	P值	高表达组	低表达组	t	P值
反应缺乏	10.48±3.65	10.85±2.92	0.51	0.0571	10.69±2.96	9.98±2.16	2.08	0.0613	10.13±2.78	10.62±3.61	1.87	0.0611
思维障碍	11.57±1.93	11.62±2.15	1.03	0.0611	10.48±2.48	11.05±1.79	1.51	0.0565	11.46±1.61	10.75±2.03	2.08	0.0573
激活性	7.42±1.80	8.18±2.97	2.05	0.0511	6.28±2.24	8.72±2.03	5.86	0.0091	5.46±1.90	8.14±2.23	4.88	0.0317
偏执	8.19±2.61	8.94±2.13	2.51	0.0607	7.83±2.72	8.23±1.98	2.64	0.0591	7.78±3.01	8.06±2.69	1.85	0.0721
抑郁	11.23±2.38	12.62±3.96	1.18	0.0513	11.62±3.52	11.69±2.96	0.83	0.0632	12.15±2.12	12.63±1.74	1.75	0.0833
攻击性	15.91±2.85	16.63±3.56	2.16	0.0564	16.75±3.13	20.39±4.01	5.12	0.0080	16.06±4.56	18.79±4.66	5.11	0.0090

表5 病例组lncRNA高表达组和低表达组阳性、阴性症状的比较(±s)

因子	NONHSAT089447		t	P值	NONHSAT021545		t	P值	NONHSAT041499		t	P值
因子	高表达组	低表达组	t	P值	高表达组	低表达组	t	P值	高表达组	低表达组	t	P值
反应缺乏	10.48±3.65	10.85±2.92	0.51	0.0571	10.69±2.96	9.98±2.16	2.08	0.0613	10.13±2.78	10.62±3.61	1.87	0.0611
思维障碍	11.57±1.93	11.62±2.15	1.03	0.0611	10.48±2.48	11.05±1.79	1.51	0.0565	11.46±1.61	10.75±2.03	2.08	0.0573
激活性	7.42±1.80	8.18±2.97	2.05	0.0511	6.28±2.24	8.72±2.03	5.86	0.0091	5.46±1.90	8.14±2.23	4.88	0.0317
偏执	8.19±2.61	8.94±2.13	2.51	0.0607	7.83±2.72	8.23±1.98	2.64	0.0591	7.78±3.01	8.06±2.69	1.85	0.0721
抑郁	11.23±2.38	12.62±3.96	1.18	0.0513	11.62±3.52	11.69±2.96	0.83	0.0632	12.15±2.12	12.63±1.74	1.75	0.0833
攻击性	15.91±2.85	16.63±3.56	2.16	0.0564	16.75±3.13	20.39±4.01	5.12	0.0080	16.06±4.56	18.79±4.66	5.11	0.0090

[1]	Najjar S, Pearlman DM. Neuroinflammation and white matter pathology in schizophrenia: systematic review[J]. Schizophr Res, 2015, 161(1): 102-112.
[2]	Tandon R, Gaebel W, Barch DM, et al. Definition and description of schizophrenia in the DSM-5[J]. Schizophr Res, 2013, 150(1): 3-10.
[3]	Lang UE, Puls I, Muller DI, et al. Molecular mechanisms of schizophrenia[J]. Cell Physiol Biochem, 2007, 20(6): 687-702.
[4]	Gogos JA, Gerber DJ. Schizophrenia susceptibility genes: emergence of positional candidates and future directions[J]. Trends Pharmacol Sci, 2006, 27(4): 226-233.
[5]	Sullivan PF, Kendler KS, Neale MC. Schizophrenia as a complex trait: evidence from a meta-analysis of twin studies[J]. Arch Gen Psychiatry, 2003, 60(12): 1187-1192.
[6]	Greenwood TA, Braff DL, Light GA, et al. Initial heritability analyses of endophenotypic measures for schizophrenia: the consortium on the genetics of schizophrenia[J]. Arch Gen Psychiatry, 2007, 64(11): 1242-1250.
[7]	Kim Y, Zerwas S, Trace SE，et al. Schizophrenia genetics: where next[J]. Schizophr Bull, 2011, 37(3): 456-463.
[8]	Beveridge NJ, Tooney PA, Carroll AP, et al. Dysregulation of miRNA 181b in the temporal cortex in schizophrenia[J]. Hum Mol Genet, 2008, 17(8): 1156-1168.
[9]	Gardiner E, Beveridge NJ, Wu JQ, et al. Imprinted DLK1-DIO3 region of 14q32 defines a schizophrenia-associated miRNA signature in peripheral blood mononuclear cells[J]. Mol Psychiatry, 2012，17(8): 827-840.
[10]	张理义，卢正斌，孙欣羊，等. 精神分裂症患者血浆microRNA异常表达的对照研究[J]. 中华行为医学与脑科学杂志，2013，22(12)：1095-1098.
[11]	Zhou R, Yuan P, Wang Y, et al. Evidence for selective microRNAs and their effectors as common long-term targets for the actions of mood stabilizers[J]. Neuropsychopharmocol, 2009, 34(6): 1395-1405.
[12]	Okazaki Y, Furuno M, Kasukawa T, et al. Analysis of the mouse transcriptome based on functional annotat ion of 60, 770 full-length cDNAs[J]. Nature, 2002, 420(6915): 563-573.
[13]	Guttman M, Amit I, Garber M, et al. Chromatin signature reveals over a thousand highly conserved large non-coding RNAs in mammals[J]. Nature, 2009, 458(7235)：223-227.
[14]	Swiezewski S, Liu F, Magusin A，et al. Cold-induced silencing by long antisense transcripts of an Arabidopsis Polycomb target[J]. Nature, 2009, 462(7274)：799-802.
[15]	Houseley J, Rubbi L, Grunstein M，et al. A ncRNA modulates histone modification and mRNA induction in the yeast GAL gene cluster[J]. Mol Cell, 2008，32(5)：685-695.
[16]	Martianov I, Ramadass A, Serra Barros A，et al. Repression of the human dihydrofolate reductase gene by a non-coding interfering transcript[J]. Nature, 2007, 445(7128)：666-670.
[17]	Kino T, Hurt DE, Ichijo T，et al. Noncoding RNA gas5 is a growth arrest- and starvation-associated repressor of the glucocorticoid receptor[J]. Sci Signal, 2010, 3(107)：ra8.
[18]	Faghihi MA, Zhang M, Huang J, et al. Evidence for natural antisense transcript-mediated inhibition of microRNA function[J]. Genome Biol, 2010, 11(5)：R56.
[19]	Gogos JA, Gerber DJ. Schizophrenia susceptibility genes: emergence of positional candidates and future directions[J]. Trends Pharmacol Sci, 2006, 27(4)：226-233.
[20]	司天梅，杨建中，舒良，等. 阳性和阴性症状量表(PANSS，中文版)的信、效度研究[J]. 中国心理卫生杂志，2004, 18(1)：45-47.
[21]	Shi W, Du J, Qi Y, et al. Aberrant expression of serum miRNAs in schizophrenia[J]. J Psychiatr Res, 2012, 46(2)：198-204.
[22]	Fan HM, Sun XY, Guo W, et al. Differential expression of microRNA in peripheral blood mononuclear cells as specific biomarker for major depressive disorder patients[J]. J Psychiatr Res, 2014，59：45-52.
[23]	Burmistrova OA, Goltsov AY, Abramova LI，et al. MicroRNA in schizophrenia: genetic and expression analysis of miR-130b (22q11)[J]. Biochemistry(MOSC), 2007, 72(5)：578-582.
[24]	Zhu Y, Kalbfleisch T, Brennan MD，et al. A MicroRNA gene is hosted in an intron of a schizophrenia-susceptibility gene[J]. Schizophr Res, 2009，109(1-3)：86-89.
[25]	Xu X. Same computational analysis, different miRNA target predictions[J]. Nature methods, 2007, 4(3)：191.
[26]	Vincent JB, Petek E, Thevarkunnel S, et al. The RAY1/ST7 tumor-suppressor locus on chromosome 7q31 represents a complex multi-transcript system[J]. Genomics, 2002, 80(3)：283-294.
[27]	Ishizuka A, Hasegawa Y, Ishida K，et al. Formation of nuclear bodies by the lncRNA Gomafu-associating proteins Celf3 and SF1[J]. Genes Cells, 2014, 19(9): 704-721.
[28]	Popkie AP, Zeidner LC, Albrecht AM, et al. Phosphatidylinositol 3-kinase (PI3K) signaling via glycogen synthase kinase-3 (Gsk-3) regulates DNA methylation of imprinted loci[J]. J Biol Chem, 2010, 285(53): 41337-41347.
[29]	Ivashchenko A, Berillo O, Pyrkova A，et al. Binding sites of miR-1273 family on the mRNA of target genes[J]. Biomed Res Int, 2014, 2014：620530.
[30]	American Psychiatric Association. Diagnostic and statistical manual mental disorder(Fifth edition)[M]. American Psychiatry Publishing, Arlington, 2013: 87-120.

[1]	朱韵莹, 高晓琳, 戈艳萍, 王张嵩, 林钊宇, 李劲松, 武东辉. 缺氧相关的长链非编码RNA LINC00970在唾液腺腺样囊性癌中的表达及其作用[J]. 中华口腔医学研究杂志(电子版), 2023, 17(03): 210-217.
[2]	左雯鑫, 袁理, 杨天慧, 汤剑明, 周芷伊, 何飞. 长链非编码RNA基因芯片技术筛选口腔扁平苔藓唾液外泌体差异表达基因[J]. 中华口腔医学研究杂志(电子版), 2022, 16(04): 208-218.
[3]	张博, 韩威, 郝少龙, 李泽乾, 纪智礼. 竞争内源性RNA在胰腺癌研究中的进展[J]. 中华普外科手术学杂志(电子版), 2023, 17(02): 213-216.
[4]	唐国军, 洪余德, 赵崇玉, 李辽源. 基于TCGA数据库Wnt相关长链非编码RNA构建肾乳头状细胞癌预后模型[J]. 中华腔镜泌尿外科杂志(电子版), 2023, 17(03): 270-275.
[5]	黄军杰, 王烈, 赵虎, 夏印, 张再重. lncRNA作为ceRNA参与婴幼儿血管瘤发生发展机制的研究进展[J]. 中华细胞与干细胞杂志(电子版), 2022, 12(06): 360-366.
[6]	王楚风, 蒋安. 原发性肝癌的分子诊断[J]. 中华肝脏外科手术学电子杂志, 2023, 12(05): 499-503.
[7]	莫建涛, 杨沛泽, 曹瑞奇, 马清涌, 王铮, 仵正, 周灿灿. 基于生物信息学分析构建肝内胆管细胞癌患者铁死亡相关lncRNA预后模型[J]. 中华肝脏外科手术学电子杂志, 2023, 12(02): 185-189.
[8]	方蕊, 宋旭东. 非编码核糖核酸与白内障相关的研究进展[J]. 中华眼科医学杂志(电子版), 2023, 13(02): 94-98.
[9]	王建鹏, 廖勇仕, 丁文聪, 李冲, 陈锐. lncRNA在创伤性脑损伤中的研究进展[J]. 中华神经创伤外科电子杂志, 2022, 08(06): 365-370.
[10]	王健, 赵海剑, 孙静, 张晓雨, 陈柏羽. LncRNA SNHG4表达与结直肠癌预后的关系[J]. 中华消化病与影像杂志(电子版), 2023, 13(03): 139-144.
[11]	张慧锋, 张弸, 朱晓蔚, 于鸿. 外泌体长链非编码RNA在胃癌中的研究进展[J]. 中华消化病与影像杂志(电子版), 2023, 13(01): 46-49.
[12]	王亚飞, 吴振彪. 自身抗体在皮肌炎患者管理中的应用[J]. 中华临床医师杂志(电子版), 2022, 16(08): 796-800.
[13]	姚珍珍, 陈昂昂, 周亚楠, 赵高峰, 张申帅, 翟金国, 陈敏. 精神分裂症认知功能损害的特点、机制及干预方式研究进展[J]. 中华诊断学电子杂志, 2023, 11(01): 28-32.
[14]	孙振晓, 刘化学, 任德菊. 烦渴-间歇性低钠血症-精神病综合征诊断学特征并文献复习[J]. 中华诊断学电子杂志, 2022, 10(04): 266-269.
[15]	苏淼, 赵东强. 肝内胆管癌预后因素的研究进展[J]. 中华胃肠内镜电子杂志, 2023, 10(01): 62-66.

阅读次数

全文

摘要

选择文件类型/文献管理软件名称

选择包含的内容

A study on the relation of positive and negative symptoms to long non-coding RNAs with altered expressions in schizophrenia

模态框（Modal）标题

选择文件类型/文献管理软件名称

选择包含的内容

A study on the relation of positive and negative symptoms to long non-coding RNAs with altered expressions in schizophrenia